Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Huajiyuan Biotechnology Development Co., Ltd. is a specialized biotechnology firm located in the Wuhan National Bio-industry Park (Biolake), China. The company is dedicated to providing high-quality biological reagents and contract research services to the global life sciences community. Its primary product offerings include a vast catalog of monoclonal and polyclonal antibodies, recombinant proteins, and sensitive ELISA kits. Huajiyuan also provides tailored technical services such as custom antibody generation, gene synthesis, and large-scale protein expression and purification. These products and services support a wide range of applications in basic research, drug discovery, and diagnostic kit development. The company maintains a strong focus on quality control and technical innovation to meet the evolving needs of researchers and pharmaceutical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 武汉华纪元生物技术开发有限公司.